Aspire Biopharma Holdings, INC. (ASBPW) — DEF 14A Filings
All DEF 14A filings from Aspire Biopharma Holdings, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Aspire Biopharma Seeks Reverse Split, Note Conversion Approval
— Sep 23, 2025 Risk: high
Aspire Biopharma Holdings, Inc. (ASBPW) is seeking stockholder approval for a reverse stock split and the issuance of shares related to convertible promissory n -
PowerUp Acquisition Corp. Schedules Extraordinary General Meeting for May 17, 2024
— May 1, 2024 Risk: medium
PowerUp Acquisition Corp. (ASBPW) filed a Proxy Statement (DEF 14A) with the SEC on May 1, 2024. PowerUp Acquisition Corp. will hold an extraordinary general me
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX